BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Allakos Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-01-18 4:32 pm Purchase |
2024-01-16 | 13G | Allakos Inc. ALLK |
BIOTECHNOLOGY VALUE FUND L P | 16,552,417 18.900% |
8,000,000![]() (+93.54%) |
Filing |
2024-01-18 4:29 pm Purchase |
2023-12-31 | 13G | Allakos Inc. ALLK |
BIOTECHNOLOGY VALUE FUND L P | 8,552,417 9.800% |
3,545,496![]() (+70.81%) |
Filing |
2022-09-29 4:28 pm Purchase |
2022-09-19 | 13G | Allakos Inc. ALLK |
BIOTECHNOLOGY VALUE FUND L P | 5,006,921 5.900% |
5,006,921![]() (New Position) |
Filing |